Trypsin and Chymotrypsin Inhibitors in Insects and Gut Leeches

Author(s): Liliane Schoofs, Elke Clynen, Michel Salzet

Journal Name: Current Pharmaceutical Design

Volume 8 , Issue 7 , 2002


Become EABM
Become Reviewer
Call for Editor

Abstract:

The constant increase of life expectancy is associated with major ageing of developed populations. This indicates that the new century will have one of most epidemic progressions of cardiovascular, cancer and inflammatory diseases. The high challenge for medical research is to compress such morbidity. In these conditions, invertebrates have demonstrated to be truly useful models in drug discovery for such ageing diseases. The last decade, drug discovery in leeches has opened the gate of new molecules to treat emphysema, coagulation, inflammation, dermitis and cancer. Also other invertebrates such as insects, which evolved from the annelids, harvest potential interesting molecules, such as serine protease inhibitors that can be exploited by the medical industry.

Keywords: trypsin, chymotrypsin inhibitors, insects, gut leeches, serine protease inhibitors, hirudo medicinalis, therostasin

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 8
ISSUE: 7
Year: 2002
Page: [483 - 491]
Pages: 9
DOI: 10.2174/1381612023395718
Price: $65

Article Metrics

PDF: 6